[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: Volume 24, Issue 1 (1-2026) ::
Int J Radiat Res 2026, 24(1): 193-198 Back to browse issues page
Value of quantitative MRI combined with blood CTC in predicting the prognosis of neoadjuvant chemotherapy for breast cancer
W. Junwu , L. Yi , T. Lidong , L. Qichao
Department of Breast Surgery, Chengdu Xinhua Hospital, Chengdu, Sichuan, China , wangjunwudf@163.com
Abstract:   (55 Views)
Background: To analyze the value of quantitative parameters of magnetic resonance imaging (MRI) combined with circulating tumor cells (CTC) in predicting the prognosis of neoadjuvant chemotherapy (NAC) for breast cancer. Materials and Methods: Ninety-eight breast cancer patients treated with NAC from January 2022 to January 2024 at our institution were collected. Pathological complete remission (pCR) was evaluated 2 weeks after the end of NAC. According to pCR, the patients were divided into pCR group (n=34) and non-pCR group (n=64). The volume transfer constant (Ktrans), extravascular extracellular space volume ratio (Ve), rate constant (Kep), and positive rate of CTC were compared between the two groups before and after treatment. The area under the receiver operating characteristic (ROC) curve (AUC) was used to express the prognostic value. Results: Among the 98 patients, 34 patients achieved pCR, with a rate of 34.69%. After treatment, Ktrans, Kep, and positive rate of CTC were lower than those before treatment (P<0.05), and were lower in the pCR group than in the non-pCR group (P<0.05). Ktrans, Kep, and positive rate of CTC were positively correlated with TNM staging (P<0.05). The AUCs of Ktrans, Kep, and positive rate of CTC joint prediction for predicting pCR after NAC for breast cancer was 0.847, which was larger than separate prediction. The sensitivity and specificity of joint prediction were 67.65% and 90.38%. Conclusion: The quantitative MRI indexes combined with blood CTC can effectively predict NAC prognosis in breast cancer patients.
Keywords: Breast neoplasms, neoadjuvant therapy, magnetic resonance imaging, circulating tumor cell.
Full-Text [PDF 967 kb]   (8 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Junwu W, Yi L, Lidong T, Qichao L. Value of quantitative MRI combined with blood CTC in predicting the prognosis of neoadjuvant chemotherapy for breast cancer. Int J Radiat Res 2026; 24 (1) :193-198
URL: http://ijrr.com/article-1-6903-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 1 (1-2026) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.1 seconds with 50 queries by YEKTAWEB 4741